Having a hobby is linked to fewer depressive symptoms and higher levels of happiness, self-reported health and life satisfaction among people aged 65 and over, and this holds true across 16 countries on three continents, ...
Sep 11, 2023
0
206
A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ...
Feb 1, 2022
0
65
Researchers from the University of Oxford have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines—identifying ...
Oct 14, 2022
0
129
A grim prediction made half a decade ago by University of Pittsburgh School of Public Health epidemiologists and modelers has come true: More than 100,000 people are now dying from drug overdoses annually in the U.S. The ...
May 25, 2022
0
112
Measuring the viral load of people infected with SARS-CoV-2 is one of the main factors in evaluating the infectiousness of COVID-19 patients. Viral load can be influenced by the infecting SARS-CoV-2 variant as well as the ...
Apr 13, 2022
0
220
Using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common chronic diseases, including diabetes, hypertension, obesity, and sleep apnea, Vanderbilt ...
Oct 12, 2022
0
110
Cambridge scientists have successfully trialed an artificial pancreas for use by patients living with type 2 diabetes. The device—powered by an algorithm developed at the University of Cambridge—doubled the amount of ...
Jan 11, 2023
0
104
Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially ...
Sep 5, 2022
0
157
An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy ...
Aug 9, 2022
0
945
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment—which depletes the B cells that contribute to the MS attacks—are able to mount robust T-cell responses to the mRNA COVID-19 ...
Sep 15, 2021
0
176
